Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Unknown 2Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 50Carcinoma, Non-Small-Cell Lung 36Ovarian Neoplasms 35Stomach Neoplasms 31Esophageal Neoplasms 26Uterine Cervical Neoplasms 20Esophageal Squamous Cell Carcinoma 18Fallopian Tube Neoplasms 16Lung Neoplasms 13Carcinoma, Ovarian Epithelial 13Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Neoplasms 8Carcinoma, Squamous Cell 8Recurrence 7Neoplasm Metastasis 6Endometrial Neoplasms 6Advanced Gastric Cancer 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Nasopharyngeal Neoplasms 5Hypopharyngeal Neoplasms 4Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Laryngeal Neoplasms 3Carcinoma 3Anus Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2

Interventions

Folfox protocol 3Fluorouracil 3Drug Therapy 3Cisplatin 3apatinib 2anlotinib 2Paclitaxel 2Oxaliplatin 2Leucovorin 2Capecitabine 2Bevacizumab 2sintilimab 1pyrotinib 1pemigatinib 1huachansu 1donafenib 1Trastuzumab 1Sorafenib 1Radiotherapy 1Physical Conditioning, Human 1Microspheres 1Irinotecan 1Immune Checkpoint Inhibitors 1Docetaxel 1Chemoradiotherapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Digestive System Neoplasms × Paclitaxel × Clear all
NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown
116 enrolled
Gastrointestinal

Digestive System Neoplasms

NCT02644863 2016-05-24

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Shenzhen Hornetcorn Bio-technology Company, LTD

Phase 2 Unknown
60 enrolled
Gastrointestinal

Digestive System Neoplasms, Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡